I
I. C. Henderson
Researcher at University of Oxford
Publications - 2
Citations - 1635
I. C. Henderson is an academic researcher from University of Oxford. The author has contributed to research in topics: Randomized controlled trial & Tamoxifen. The author has an hindex of 2, co-authored 2 publications receiving 1610 citations.
Papers
More filters
Journal Article
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women
I. C. Henderson,H. Mouridsen,O. Abe,M. Abeloff,D. Ahmann,K. Andersen,M. Baum,A. R. Bianco,F. Boccardo,G. Bonadonna,M. Buyse,Aman U. Buzdar,P. Carbone,J. Carpenter,R. Chlebowski,Rory Collins,R. Cooper,J. Crowley,Jack Cuzick +18 more
TL;DR: This overview was able to demonstrate particularly clearly that both tamoxifen and cytotoxic therapy can reduce five-year mortality, and showed that combination chemotherapy was significantly more effective than single-agent therapy.
Journal ArticleDOI
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group.
I. C. Henderson,H. Mouridsen,O. Abe,M. Abeloff,D. Ahmann,K. Andersen,Michael Baum,Angelo Raffaele Bianco,F. Boccardo,Gianni Bonadonna,Marc Buyse,Aman U. Buzdar,P. Carbone,J. Carpenter,Rowan T. Chlebowski,Rory Collins,R. Cooper,J. Crowley,Jack Cuzick +18 more
TL;DR: In this paper, the authors sought information worldwide on mortality according to assigned treatment in all randomized trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early breast cancer (with or without regional lymph node involvement).